In this regard, we were particularly interested in the significant CDDO-2P-Im-dependent downregulation of IL10 and TGFβ signaling, as both of these pathways have immunosuppressive functions which may inhibit the anti-cancer immune response [26, 65]. Here, TGFB1 is linked to cancer.